Milan, Italy (September 21, 2024)

Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its attendance at 2024 Italian Tech Week.

Marco Ferroni, Chief Executive Officer, will be attending the event, held September 25-27, 2024 in Turin, Italy.

is Italy’s largest technology and innovation event, bringing together entrepreneurs, innovators, investors, and tech enthusiasts from around the world. The event typically takes place in Turin, featuring keynote speeches, panel discussions, networking opportunities, and workshops focused on the latest trends in technology, startups, and innovation.

About MgShell:

MgShell, headquartered in Milan, Italy, is a preclinical-stage drug delivery company focused on developing a magnesium-based drug delivery platform capable of reshaping patient care, enhancing treatment adherence for patients suffering from retinal diseases, and lowering healthcare expenses.